Stamm.bio is a biotechnology company focused on revolutionizing biomanufacturing by making it easy, scalable, and repeatable. Founded in 2016, the company operates in the biopharma industry and serves clients ranging from small biotech startups to large pharmaceutical companies. Stamm.bio's core product, the Bioprocessor, downsizes an entire biotech facility into a plug-and-play desktop unit using laminar flow technology. This innovation allows for continuous production and unidirectional flow, making bioprocesses more efficient and accessible. The company also leverages microfluidics and 3D printing to create a zero marginal cost of innovation in biotech. Stamm.bio generates revenue through sales of its Bioprocessor units, partnerships, and collaborations with other biotech firms. The business model focuses on decentralizing bioprocesses and democratizing access to biotechnology products, enabling partners to concentrate on groundbreaking discoveries.

Keywords: Biomanufacturing, Bioprocessor, Laminar Flow, Continuous Production, Microfluidics, 3D Printing, Biopharma, Desktop Unit, Scalable, Plug-and-Play.